However, studies to date have not identified any profound associations between somatic genetic alterations and germline HSD3B1 in prostate cancer, and thus, a bias because of co-occurring somatic mutations is unlikely (25, 26). The gene discussed is HSD3B1; the disease is prostate carcinoma.